• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
LGND

LGND

Ligand Pharmaceuticals Incorporated

NASDAQHealthcareBiotechnologyUS

USD234.40

+1.64 (+0.70%)

Rating:B+

Company Profile

CEO

Todd C. Davis

IPO Date

1992-11-18

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$232.57

Prev. Close

$232.76

Day Low

$229.52

Day High

$234.88

52W Low

$102.50

52W High

$247.38

Market Cap

$4.70B

Volume

0.15M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
Analyst Consensus
Buy

Strong Buy

0

Buy

12

Hold

4

Sell

1

Strong Sell

0

Analyst Grades
DateFirmPreviousNew GradeAction
8 May 2026RBC CapitalOutperformOutperformmaintain
30 Apr 2026HC Wainwright & Co.BuyBuymaintain
28 Apr 2026RBC CapitalOutperformOutperformmaintain
15 Apr 2026
Citigroup
Buy
Buy
maintain
14 Apr 2026HC Wainwright & Co.BuyBuymaintain
24 Mar 2026CitigroupBuyBuymaintain
27 Feb 2026OppenheimerOutperformOutperformmaintain
24 Feb 2026HC Wainwright & Co.BuyBuymaintain
10 Dec 2025StifelBuyBuymaintain
10 Dec 2025RBC CapitalOutperformOutperformmaintain